
Natalie Cusano MD
Diabetes, Lipid Metabolism, Osteoporosis & Bone Metabolism Medicine
Professor of Medicine, Zucker School of Medicine at Hofstra/Northwell
Join to View Full Profile
110 East 59th Street8th Floor/Suite 8BNew York, NY 10022
Phone+1 212-434-4972
Fax+1 212-434-4974
Dr. Cusano is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Natalie Cusano received her undergraduate training at the Massachusetts Institute of Technology and her medical training at the Boston University School of Medicine. She completed residency training in Internal Medicine at Beth Israel Deaconess Medical Center and fellowship training in Endocrinology, Diabetes and Metabolism at the College of Physicians and Surgeons, Columbia University. Dr. Cusano is a Professor of Medicine at the Zucker School of Medicine at Hofstra/Northwell. She is a member of the Katz Institute for Women’s Health.
Dr. Cusano serves on the editorial board of Endocrine Practice. She serves as a member of the Endocrine Society Endocrine Board Review Faculty Group, writing questions for the board review course for the Calcium and Bone section. She serves as a member of the American Association of Clinical Endocrinology Clinical Practice Guideline Oversight Committee. She lists over 100 publications of original research, invited articles, chapters and abstracts in the field of metabolic bone disease.
Education & Training
New York Presbyterian Hospital (Columbia Campus)Fellowship, Endocrinology, Diabetes, and Metabolism, 2009 - 2012
Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 2006 - 2009
Boston University School of MedicineClass of 2006
Certifications & Licensure
NY State Medical License 2009 - 2026
American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Castle Connolly Top Doctor 2022-2023
- CMS Meaningful Use Stage 1 Certification Allscripts TouchWorks EHR, Allscripts, 2014-2017
- CMS Meaningful Use Stage 2 Certification Allscripts TouchWorks EHR, Allscripts, 2014-2017
Publications & Presentations
PubMed
- Early U.S. Real-World Treatment Patterns and Outcomes in Palopegteriparatide Treatment for Patients With Hypoparathyroidism.Timothy Graham, Dolores M Shoback, Lisa Abbott, Sara Lubitz, Gary Edelson
Endocrine Practice. 2025-12-01 - 2 citationsManagement of Primary Hyperparathyroidism: Historical and Contemporary Perspectives.Sheryl T Y Htoo, Natalie E Cusano
Endocrine Practice. 2025-11-01 - 3 citationsBest practice recommendations for the diagnosis and management of hypoparathyroidism.Aliya A Khan, Dalal S Ali, John P Bilezikian, Sigridur Björnsdottir, Michael T Collins
Metabolism. 2025-10-01
Journal Articles
- Comparative Effect of rhPTH(1‐84) on Bone Mineral Density and Trabecular Bone Score in Hypoparathyroidism and Postmenopausal OsteoporosisMishaela R Rubin, Donald J McMahon, John P Bilezikian, Natalie E Cusano, Journal of Bone and Mineral Research
Press Mentions
Patients with Hypoparathyroidism Warned of Extended NATPARA RecallJanuary 24th, 2020
The Latest on Osteoporosis Treatment and DiagnosisMay 5th, 2023
Can a Simple Blood Test Predict Your Osteoporosis Risk Early?December 30th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:









